U.S. flag

An official website of the United States government

GTR Home > Tests > Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel

Indication

This is a clinical test intended for Help: Diagnosis, Pre-symptomatic, Therapeutic management

Clinical summary

Help

A primary or metastatic malignant neoplasm involving the bladder. [from NCI]

Clinical features

Help

Imported from Human Phenotype Ontology (HPO)

  • Bladder neoplasm
  • Transitional cell carcinoma of the bladder

Conditions tested

Target population

Help

This test provides a comprehensive analysis of the genes associated with inherited arrhythmia and cardiomyopathy conditions. Given the clinical overlap between different arrhythmia and cardiomyopathy conditions, comprehensive testing enables a more efficient evaluation of multiple conditions based on a single indication for testing.

Citations

Not provided

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.